NCT07217600 2025-10-20
Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy
Chongqing University Cancer Hospital
Phase 4 Recruiting
Clinical Trials
11 trialsNCT07038551 2025-07-02
Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study
International University of Health and Welfare
Phase 4 Recruiting
NCT05841849 2023-05-03
Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4 Not yet recruiting
NCT03571126 2021-07-13
Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer
Zunyi Medical College
Phase 4 Unknown
NCT02532634 2018-05-11
RAPA
Kangdong Sacred Heart Hospital
Phase 4 Completed
NCT01432015 2017-03-28
Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting
Gynecologic Oncology Associates
Phase 4 Completed
NCT01913990 2017-01-30
ER11-02
Ottawa Hospital Research Institute
Phase 4 Unknown
NCT03017391 2017-01-11
Treatment Algorithm for Nausea and Vomiting in the Palliative Phase
Radboud University Medical Center
Phase 4 Unknown
NCT02576327 2016-12-30
A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation
Peking University
Phase 4 Unknown
NCT01481831 2012-12-31
ESPNV
Shanghai Changzheng Hospital
Phase 4 Completed
NCT00415103 2009-09-18
AMENO-2
PETHEMA Foundation
Phase 4 Completed